Patient Services

Patient Services

Multiple sclerosis continuity care

Ongoing management of disease modifying therapies

  1. Interferons (Avonex, Betaseron, Extavia, Rebif)
  2. Glatimar Acetate (Copaxone)
  3. Natalizumab (Tysabri)
  4. Fingolimod (Gilenya)
  5. Teriflunomide (Aubagio)
  6. Dimethylfumarate

 

Symptomatic management of MS symptoms, including

  1. Ambulatory dysfunction
  2. Spasticity
  3. Fatigue
  4. Neurogenic bladder
  5. Cognitive dysfunction

 

Therapeutic management evaluations

  1. Injection training
  2. Risk stratification with Tysabri
  3. First dose observation with Gilenya
  4. Side effect management


Consultative second opinion services

Neuropsychological evaluation and management

Physical and occupational therapy

Social work services

Community support programs

 

Clinic Home

Mission

Clinical Services

Research

Education

Clinic Team

Directions

Contact Information

How You Can Help

sidebar clinic name big